Drugs / Vitamin A
Vitamin A
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | AQUASOL A | — | 1949-05-18 | fda.gov ↗ |
Trials 43 · a red edge is where a trial was stopped
19481949195019511952195319541955195619571958195919601961196219631964196519661967196819691970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
Also used as a comparator or background therapy in 14 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06450925 Comparator | Mar 2025 → Aug 2027 expected | graft versus host disease, vitamin A deficiency, vitamin D deficiency | Children's Hospital Medical Center, Cincinnati | Recruiting | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00114868 Comparator | Jun 1998 → Apr 2001 | — | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| Phase 3 | NCT00396500 Background | Apr 1994 → Dec 1996 | helminthiasis, nutritional deficiency disease | King George's Medical University | Completed | No outcome recorded |
| Phase 48 trials | ||||||
| Phase 4 | NCT03112382 Comparator | Nov 2015 → May 2017 | type 2 diabetes mellitus | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT01414972 Comparator | May 2010 → Jan 2011 | atherosclerosis | Tehran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 4 | NCT01705457 Comparator | Feb 2010 → Feb 2013 | relapsing-remitting multiple sclerosis | Tehran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 4 | NCT00963222 Comparator | Sep 2009 → Sep 2011 | atherosclerosis | Tehran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 4 | NCT00514891 Comparator | Aug 2007 → Jun 2012 | — | Bandim Health Project | Terminated | No outcome recorded |
| Phase 4 | NCT00417404 Comparator | Jan 2007 → Dec 2009 | retinopathy of prematurity | Glasgow Royal Infirmary | Completed | No outcome recorded |
| Phase 4 | NCT00431691 Comparator | Sep 2006 → Dec 2007 | escherichia coli infection, retinal disorder | Medical University of Vienna | Completed | No outcome recorded |
| Phase 4 | NCT03152474 Comparator | Feb 1993 → Jan 2000 | infectious disease with sepsis | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT00558480 Comparator | Jul 2009 → Jul 2011 | latent tuberculosis infection | Medical Research Council Unit, The Gambia | Withdrawn | No outcome recorded |
| — | NCT00936091 Comparator | May 2007 → Aug 2008 | iron deficiency anemia, parasitic intestinal disorder | Sana'a University | Completed | No outcome recorded |
| — | NCT00272116 Background | Feb 1998 → Feb 2000 | diarrheal disease, pneumonia | Society for Applied Studies | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 57 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamin A | “with daily multivitamins [vitamin A (300 microg, as retinol palmitate), vitamin E (6 mg tocopherol equivalents), vitamin B-12 (0.9 microg), vitamin C (15 mg), riboflavin (0.5...” PMID 19535425 ↗ Jun 200955“Fat-soluble vitamins is administered 0.5 piece/kg (equals to 1150 U/kg vitamin A，200 U/kg vitamin D, 3.2 U/kg vitamin E) intravenously every day until the baby achieve full...” NCT03876704 ↗ “vitamin A 0.9 mg, vitamin E 100 mg” PMID 18296460 ↗ Feb 2008 “2 mg vitamin A \[retinol\]” NCT01437826 ↗ “vitamin A 6600 IU” NCT00963131 ↗ |
| Known as | Aquasol A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00417404 ↗ |
| Known as | retinol palmitate | “with daily multivitamins [vitamin A (300 microg, as retinol palmitate), vitamin E (6 mg tocopherol equivalents), vitamin B-12 (0.9 microg), vitamin C (15 mg), riboflavin (0.5...” PMID 19535425 ↗ Jun 2009 |
| Known as | retinyl palmitate | “The Vitamin A treatment group will receive 5,000 IU of Vitamin A (retinyl palmitate) by intramuscular injection 3 times weekly for 28 days starting on postnatal day 2.” NCT00063596 ↗2“supplementation with 25000 IU preformed vitamin A (retinyl palmitate) or placebo” NCT01414972 ↗ “Vitamin A (retinyl palmitate)” NCT00198718 ↗ |
| Known as | vitamin A and E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03112382 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT00063596 ↗ |